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Abstract
Elevated concentrations of testosterone and its synthetic analogs may induce changes in cardiovascular function. However,
the effects of the combination of anabolic/androgenic steroid (AAS) treatment and exercise training on systolic and diastolic
cardiac function are poorly understood. In the present study, we aimed to investigate the effects of low-dose steroid
treatment (stanozolol) on cardiac contractile parameters when this steroid treatment was combined with exercise training
in rats and the effects of chronic steroid treatment on the Frank-Starling (length-tension curves) relationship. Male Wistar
rats were randomly assigned to one of four groups: U (untrained), US (untrained and treated with stanozolol 5 mg/kg/
week), T (trained, 16 m/min/1 h) and TS (trained and treated with stanozolol 5 mg/kg/week). Continuous exercise training
was conducted 5 days/week for 8 consecutive weeks. The speed of the treadmill was gradually increased to a final setting of
16 m/min/1 h. Experiments were divided into two independent series: 1) central hemodynamic analysis for mean arterial
blood pressure (MAP) and cardiac output (CO) measurements and 2) isolated papillary muscle preparation in Krebs solution.
Stanozolol treatment significantly increased the MAP and the heart size in untrained and trained rats (U 11362; T 10662; US
13868 and TS 13067 mmHg). Furthermore, stanozolol significantly decreased developed tension and dT/dt (maximal and
minimal) in U rats. However, the developed tension was completely restored by training. The Frank/Starling relationship was
impaired in rats treated with stanozolol; however, again, training completely restored diastolic function. Taken together, the
present data suggest that AAS treatment is able to decrease cardiac performance (systolic and diastolic functions). The
combination of stanozolol and physical training improved cardiac performance, including diastolic and systolic functions,
independent of changes in central hemodynamic parameters. Therefore, changes in ventricular myocyte calcium transients
may play a cardioprotective role.
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Introduction
Testosterone and its synthetic analogs have been used to
increase skeletal muscle mass and enhance physical performance.
Furthermore, it is well described that anabolic/androgenic steroids
(AAS) have cardiovascular actions and that the heart is a target
tissue of AAS, and testosterone is the main physiological hormone
in this class [1,2]. One of the most popular AAS is stanozolol, a
17a-alkylate androgen derivate that exhibits greater anabolic
potency (anabolic/androgenic ratio, approximately of 30) and
slower hepatic degradation than the natural male hormone [3].
Exogenously administered AAS induce cardiac hypertrophy in vitro
and in vivo [4,5]. Furthermore, high doses of AAS administered in
conjunction with vigorous exercise training in mice leads to
cardiac hypertrophy, increased inflammatory cytokine levels and
significant stimulation of the sympathetic nervous system [6].
Therefore, the combination of such factors may predispose
subjects to myocardial injury. However, the adaptations of cardiac
muscle to chronic low-dose AAS exposure and their association
with physical exercise are still poorly understood and were the
major focus of the present study.
Stanozolol and other AAS are used as adjunct therapies for a
variety of medical conditions, e.g., to stimulate erythropoiesis in
patients with some anemia conditions, and athletes or even
sedentary subjects may use AAS to improve physical performance
or appearance [7,8]. Considering that the anabolic effects of AAS
on the cardiovascular system act in both cardiac muscle and
arteries, the chronic effects of AAS treatment may induce
differential responses in different target organs [9]. Therefore, in
the present study, we evaluated the effects of chronic anabolic
steroid treatment on isolated papillary cardiac muscle in sedentary
and exercise-trained rats. Central hemodynamic function was also
evaluated.
In a previous study, Tagarakis et al [10] showed that
testosterone impairs the response of cardiac capillary beds to
physical exercise. They showed that testosterone treatment
profoundly inhibits the exercise-induce augmented capillarization
in the heart muscle, whereas under training conditions, it leads to
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mild myocyte hypertrophy. Others have reported that the
association of physical exercise and AAS treatment leads to
cardiac fibrosis mediated by activation of angiotensin II type one
(AT-1) and mineralocorticoid receptors [11]. However, we have
no information regarding the effects of AAS on systolic and
diastolic functions in isolated cardiac muscle in combination with
the presence or absence of physical exercise training.
It has been reported that higher doses of AAS have deleterious
effects on the cardiovascular system [6,12]. However, to the best of
our knowledge, there have been few studies reporting the effects of
low-dose steroid treatment combined with exercise training on
cardiac function in rats. Thus, the main objectives of the present
study were 1) to investigate the effects of low-dose steroid
treatment (stanozolol) on cardiac contractile parameters when this
steroid treatment was used in combination with exercise training
in rats and 2) to investigate the effects of chronic steroid treatment
on the Frank-Starling (length-tension curves) relationship.
Results
After eight weeks of steroid treatment, there was no significant
difference in body weight among groups (table 1). However,
stanozolol treatment and continuous treadmill exercise, both
individually and alone, significantly reduced the serum testoster-
one level compared to that in the U group (U: 176625, T: 4062;
US: 2268; TS: 1863 ng/dl, P,0,05), as shown in figure 1A.
Testicle weight was significantly reduced as a consequence of the
treatment, as shown in Table 1. There were no differences
observed in the hematocrit levels among groups, as shown in
figure 1B. Furthermore, there was no difference in right
ventricular weight among the groups (table 1). However,
significant increases in the left ventricular and total heart weights
were found in the US and TS groups compared to their respective
untreated groups (table 1).
As observed in table 1, the basal heart rate was not significantly
different among groups. However, the basal MAP was higher in
both the US and TS groups than in the U and T groups,
respectively. The increase in MAP was mediated by an increase in
CI. Paradoxically, as shown in table 1, no differences were found
in TPR between groups.
No differences were found in Lmax, papillary weight and cross
sectional area (Table 1). The systolic and diastolic parameters of
myocardial mechanics are shown in figure 2. Significant reduc-
tions were found in the US group for developed tension
(0.5160.04 g/mm2/mg), +dT/dt (4.8160.34 g/mm2/mg/s)
and 2dT/dt (3.0060.24 g/mm2/mg/s) relative to other groups:
U (DT: 0.8960.05 g/mm2/mg; +dT/dt: 9.2060.58 g/mm2/
mg/s; 2dT/dt: 3.9760.19 g/mm2/mg/s); T (DT: 0.9660.03 g/
Figure 1. Blood sample biochemical analysis. Panel A: serum testosterone levels in ng/dl. Panel B: hematocrit percentage. Values are expressed
at the mean6 SEM for the control (C), low dose (LD) and high dose (HD). * represents significant differences (P,0.05) with respect to other groups as
determined by one-way ANOVA–Tukey test.
doi:10.1371/journal.pone.0087106.g001
Table 1. Effects on biometric, hemodynamic and contractile
parameters by association of anabolic steroid and exercise
training.
Variables U T US TS
Biometric
BW (g) 332611 299619 321621 335618
TW/BW (mg/g) 561 561 461* 361*
RV/BW (mg/g) 0.7160.11 0.6660.12 0.6660.09 0.6860.04
LV/BW (mg/g) 1.9560.04 2.0860.31 2.1160.19* 2.1660.16*
HW/BW (mg/g) 2.6660,17 2.7460.42 2.7760.26* 2.8560.25*
PW (mg) 7.860.9 7.860.8 7.861.3 7.960.7
Lmax (mm) 7.861.0 7.860.2 7.360.5 8.360.9
CSA (mm2) 1.0160.11 0.9960.09 1.0660.14 0.9760.14
Hemodynamic
HR (bpm) 363613 410621 411617 372638
MAP (mmHg) 11362 10662 13868* 13067*
CI (ml/min/100 g) 3863 3765 5564*# 5064
TPR (mmHg/ml/min) 0.9060.07 0.7560.07 0.8060.08 0.8060.12
Values expressed at mean 6 SEM of BW: body weight, TW/BW: testicle weight/
body weight, RV/BW: right ventricular weight/body weight, LV/BW: left
ventricular weight/body weight, HW/BW: heart weight/body weight, PW:
papillary weight, Lmax: muscle length papillary muscle length at optimum
length, CSA: cross-sectional area, basal levels of HR: heart rate, MAP: arterial
pressure, CI: cardiac index and TPR: total peripheral resistance in untrained (U),
trained (T), untrained+steroid (US) and trained+steroid (TS).
*represent statistical differences (P,0.05) from U and T.
#represent statistical differences (P,0.05) from TS (by ANOVA–Tukey test).
doi:10.1371/journal.pone.0087106.t001
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mm2/mg; +dT/dt: 9.5760.28 g/mm2/mg/s; 2dT/dt:
3.7460.62 g/mm2/mg/s) and TS (DT: 0.7760.08 g/mm2/mg;
+dT/dt: 8.3460.55 g/mm2/mg/s;2dT/dt: 3.0060.24 g/mm2/
mg/s).
No differences were found in the RT (U: 0.2060.01 g/mm2/
mg, T: 0.1860.01 g/mm2/mg, US: 0.1760.01 g/mm2/mg, TS:
0.1660.01 g/mm2/mg); TPT (U: 179610 ms, T: 179612 ms,
US: 17365 ms, TS: 17167 ms) or RT50% (U: 153613 ms, T:
159615 ms, US: 169611 ms, TS: 150616 ms), suggesting some
preservation of myocardium relaxation, as shown in figure 2.
The Frank-Starling relationship is expressed in g/mm2/mg/
%Lmax and is shown in Figure 3A. The slopes for untrained
stanozolol-treated rats (US: 0.01660.004) were different from
those of the U (0.03260.002) and T (0.03160.002) groups and,
curiously, from that of the TS (0.03860.004) group, suggesting a
preservation of the Frank-Starling relationship in TS rats. The
resting tension-relationship curves (Figure 3B) did not differ
among groups (U: 0.3260.050; T: 0.4360.05; US: 0.2860.02;
TS: 0.3560.02).
Discussion
The major new findings of the present study were 1) stanozolol
treatment increased blood pressure and heart size in rats, 2)
stanozolol treatment decreased developed tension and dT/dt
(maximal and minimal) in untrained rats, although training
completely restored these parameters, and 3) stanozolol treatment
impaired the Frank/starling relationship curve, but again, training
completely restored diastolic function.
The effects of steroid administration on body mass are
conflicting. There are studies showing positive effects [20], no
changes or even a reduction in body mass in response to chronic
anabolic steroid treatment [21–23]. In the present study, no
change in body mass index was observed among groups. However,
we found a significant increase in cardiac mass in stanozolol-
treated rats. A similar result was described previously [23], but
there is some controversy regarding this effect [24]. In the present
study, the differential effect of stanozolol on the left and right
ventricles suggests that the left ventricular hypertrophy was
secondary to arterial hypertension because no hypertrophy was
found in the right ventricle.
An interesting feature of the efficacy of steroid treatment is the
effect of steroids on endogenous levels of testosterone. Previous
studies have shown that stanozolol treatment significantly
decreases testicular formation in response to testosterone and
luteinizing hormone [12,25]. A significant decrease in plasma
levels of testosterone was found in the present study. Interestingly,
plasma testosterone levels significantly decreased in response to
chronic physical training. A similar result was described previously
[26,27]. However, there are studies showing no changes [28] or
even an increase in serum testosterone level in response to physical
exercise [29].
A positive correlation has been shown between AAS and arterial
hypertension, not only in rats [12,30] but also in humans [31].
However, the mechanisms underlying hypertension are not fully
understood. In the present study, stanozolol treatment increased
blood pressure in rats regardless of physical training. The increase
in blood pressure was mediated by an increase in cardiac index,
and no significant changes were found in TPR, suggesting a
preferential effect of stanozolol on cardiac tissue. Training was not
able to prevent an increase in blood pressure in response to
stanozolol but did lead to a reduction in blood pressure compared
Figure 2. Systolic and diastolic parameters. Values are expressed as the mean 6 SEM of developed tension (DT, Panel A), maximum rate of
tension development (+dT/dt, Panel B), time to peak tension (TPT, Panel C), rest tension (RT, Panel D), maximum rate of tension decline (2dT/dt,
Panel E) and (TR50%, Panel F). * represents significant differences (P,0.05) respect to other groups by one-way ANOVA–Tukey test.
doi:10.1371/journal.pone.0087106.g002
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to the US group. It has been shown that regular exercise is able to
decrease blood pressure in hypertensive subjects [32].
The heart is a target organ for AAS action; there are receptors
with a high affinity for testosterone in myocytes [33,34]. A well-
described positive correlation exists between heart hypertrophy
and heart failure that is a major independent risk factor for
cardiovascular mortality [35]. Furthermore, inflammatory cyto-
kines and excessive stimulation of the sympathetic nervous system
are involved in heart hypertrophy [6]. Therefore, the combination
of such factors may predispose one to myocardial injury. In the
present study, we found that training may protect cardiac function
in stanozolol-treated rats.
Finally, in the present study, we found that stanozolol treatment
leads to a decrease in cardiac function. However, the combination
of stanozolol treatment and physical training improved cardiac
performance, including diastolic and systolic functions. The novel
finding of the present study is that the improvement in the cardiac
performance (systolic and diastolic function) induced by physical
exercise in stanozolol-treated rats is apparently independent of
changes in central hemodynamic parameters. Therefore, changes




All animal procedures were conducted according to the
‘‘Guidelines for Ethical Care of Experimental Animals’’ and were
approved by the Institutional Ethics Committee of the Federal
University of Sa˜o Paulo (UNIFESP) School of Medicine (CEP
0648/04).
The Central Animal House of UNIFESP provided 72 intact
male Wistar rats (150–200 g), which were housed in group cages,
fed with rat chow and water ad libitum, and maintained in a room
with constant temperature (23uC) on a 12-h light:12-h dark cycle.
The animals were randomly assigned to one of four groups: U
(untrained), US (untrained and treated with stanozolol 5 mg/kg/
week), T (trained, 16 m/min/1 h), and TS (trained and with
stanozolol 5 mg/kg/week. Stanozolol was administered intramus-
cularly, and the same volume of saline was injected into the control
groups, as previously described [12]. All rats were familiarized
with treadmill running. Continuous exercise training was con-
ducted for 60 min 5 days/week for 8 consecutive weeks during the
light period of the light-dark cycle. The speed of the treadmill was
gradually increased to a final setting of 16 m/min. The exercise
training protocol was based on a previous study [13].
Biochemical analysis
Blood samples were collected via a venous catheter in the four
groups of animals, and the serum levels of testosterone were
quantified by radioimmunoassay, using standard commercially
available kits.
Hemodynamic analysis
The hemodynamic parameters were measured in conscious rats
using a Cardiomax III thermodilution system (Columbus Instru-
ments Inc., Ohio, USA), as described in previous studies [14]. In
this series of experiments, the animals were instrumented for
hemodynamic measurements at least 24 hours before the exper-
iments under halothane anesthesia (2%).
Isolated papillary muscle mechanics
Immediately after echocardiogram, the heart was quickly
removed and placed in oxygenated Krebs solution. As previously
described by our laboratory [14–18], the papillary muscle was
dissected carefully from the left ventricle, mounted between two
spring clips and placed vertically in a chamber containing Krebs
solution (28uC) oxygenated with 100% O2 at a pH of 7.4060.02.
The composition of the Krebs solution was as follows (mmol/L):
NaCl 132; KCl 4.69; CaCl2 1.5; MgSO4 1.16; KH2PO4 1.18;
C6H12O6 5.50; HEPES 20. The lower spring clip was attached to
the bottom of the chamber, and the upper spring clip was
connected by a thin steel wire to an isometric transducer (model
FT03E; Grass Instrument, Quincy, MA, USA) connected to a
micrometer for adjustment of muscle length. Preparations were
stimulated 12 times/min with 5-ms square-wave pulses through
parallel platinum electrodes at voltages that were approximately
10% greater than the minimum stimulus required to produce a
maximal mechanical response. After a 60-minute equilibration
period, during which preparations were permitted to contract
isotonically under light loading conditions (0.4 g), papillary
muscles were loaded to contract isometrically for 15 min and
stretched to the apices of their length–tension curves (Lmax). The
mechanical behavior of the papillary muscles was evaluated under
basal conditions, as well as at 98, 96, 94 and 92% of Lmax,
allowing for determination of Frank–Starling curves as described
previously [15–16]. The following parameters were measured
during isometric contractions: peak developed tension (DT),
resting tension (RT), maximum rate of tension development (+
dT/dt) and tension decline (2dT/dt), time to peak tension (TPT)
and time from peak tension to 50% relaxation (RT50%). At the
end of each experiment, muscle length at Lmax was measured,
Figure 3. Frank-Starling relationship. Values are expressed as the
mean 6 SEM of left ventricular papillary muscle developed (A) and
resting (B) length-tension curves obtained from untrained (#), trained
(N), untrained+steroid (n) and trained plus steroid (m) rats. A: straight
lines were fitted to the developed length-tension relationships using
linear regression analysis. B: the resting tension-length curves for the
four groups were fitted to mono-exponential non-linear relationships.
doi:10.1371/journal.pone.0087106.g003
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and the muscle between the two clips was blotted dry and weighed.
The muscle cross-sectional area (CSA) was calculated from the
muscle weight and length by assuming cylindrical uniformity and a
specific gravity of 1. The values were normalized to conform to
previous publications [15–19]. After the papillary muscle was
removed, left and right ventricles were separated and weighed for
posterior evaluation of biometrical parameters.
Statistical analysis
The data were expressed as the mean 6 SEM. One-way
ANOVA was used for the group comparisons followed by a post
hoc Tukey’s test. The DT–length relations were evaluated by
linear regression analysis, and the slopes were compared by one-
way ANOVA. The RT–length curves were fit to a monoexpo-
nential relation, as follows: y =b0eb1x, where b0 and b1 are the
constants of the curve. These non-linear relationships were
compared between groups by constant stiffness values. Statistical
analyses were performed with Prism software (version 4.0, San
Diego, CA, USA). Values of P,0.05 were considered statistically
significant.
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